Jul. 24 at 6:09 PM
$NVCT i think Charles or someone keeps buying more - another big batch of
$12 million or so yesterday. Are they buying for NXP800 or NXP900 or both? I am hoping for a nice surprise on NXP800 soon. If it’s good, I hope that Wall Street values it beyond just the ARID1a ovarian indication and into endometrial and possibly others with the ARID1a mutation. could be a few billion+ in TAM with read-through into these other indications. combined with NXP900 this could be a monster… I am willing to keep waiting. long time holder and lurker here